Loading
companiesCompany
CNSide Diagnostics
CNSide captures tumour cells from cerebrospinal fluid to diagnose and track leptomeningeal disease, cancer spread to the linings of the brain and spine that conventional cytology often misses.
Overview
CNSide Diagnostics runs a cerebrospinal fluid assay that captures and counts circulating tumour cells and profiles their molecular markers, used to diagnose leptomeningeal metastases and to follow them over time during treatment. Future of Cancer Care Today notes it often detects cases that conventional cytology misses; it is physician-ordered.
Similar pages
- CompanyRGCC International
Shares Circulating tumour cell capture, Liquid biopsy (ctDNA) and the tag fcct-directory.
- CompanyCanCertain
Shares Circulating tumour cell capture and the tag fcct-directory.
- CompanyBelay Diagnostics
Shares Liquid biopsy (ctDNA) and the tag fcct-directory.
- CompanyANGLE plc
Shares Circulating tumour cell capture, Liquid biopsy (ctDNA).
- CompanyMenarini Silicon Biosystems
Shares Circulating tumour cell capture, Liquid biopsy (ctDNA).
- TechnologyParsortix label-free circulating tumour cell harvest
Shares Circulating tumour cell capture, Liquid biopsy (ctDNA).
- TechnologyCellSearch circulating tumour cell count
Shares Circulating tumour cell capture, Liquid biopsy (ctDNA).